Conditions

GIVINOSTAT

Drug approval information sourced from the FDA and the PBS. Updated nightly from public government registries. Not medical advice.

Access in Australia

  • This medicine does not currently appear on the PBS Schedule, according to the Pharmaceutical Benefits Scheme. This can mean a higher out of pocket cost. Your doctor can explain the available access pathways.
  • TGA registration data for this medicine is not yet available on Voxsanity.
Updated regularly from public government registries

How it works: Histone Deacetylase Inhibitors

Drug class: Other drugs for disorders of the musculo-skeletal system

Approval status

FDA Approved

21 March 2024
US Food and Drug Administration

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Regulatory approval does not guarantee this drug is available to you. Availability in Australia depends on PBS listing status, your specific diagnosis, your doctor's assessment, and other clinical factors.

Accessing this drug in Australia

This medicine does not currently appear on the PBS Schedule. Your doctor can explain the available access pathways, which may include the TGA Special Access Scheme ↗.

This information is drawn from publicly available PBS records. It is not medical advice. Consult your doctor about access options for your specific situation.

What people have reported to the FDA

When someone believes a medicine has harmed them, they or their doctor can send a report to the US Food and Drug Administration. These are the events most often described in a sample of those reports where this medicine was recorded as the suspected cause. Reports naming it only as another medicine the person happened to be taking are excluded.

Please read this before the list below

  • A report is not proof. Anyone can submit one. The FDA does not verify them, and a report being filed does not establish that the medicine caused the event.
  • These are not rates, and cannot be turned into one. This database does not record how many people took the medicine, so there is no total to compare against. A number here says how often something was reported, never how likely it is to happen to you.
  • These are counts of reports, not of people. One person can be the subject of more than one report.
  • The illness itself appears in these reports. Events described during treatment include the condition being treated, that condition getting worse, and deaths from any cause. Being listed here does not mean the medicine caused it.
  • This is not a list of side effects. For that, read the Consumer Medicine Information leaflet that comes with the medicine, or ask your doctor or pharmacist.
  • PLATELET COUNT DECREASED — 72 reports
  • DIARRHOEA — 43 reports
  • BLOOD TRIGLYCERIDES INCREASED — 35 reports
  • ABDOMINAL DISCOMFORT — 19 reports
  • NAUSEA — 17 reports

Source: FDA Adverse Event Reporting System (FAERS), via openFDA. Counts come from a sample of 227 reports in which this medicine was recorded as the suspected cause, taken from 480 reports that mention it in any role. Because it is a sample of voluntary, unverified reports with no record of how many people took the medicine, these counts cannot be compared between medicines and are not a measure of risk. Terms describing how the medicine was used rather than an effect on the body, and terms recording the illness progressing, are not listed. Discuss any concerns with your doctor.

Approval data sourced from openFDA (CC0 licence), and the PBS schedule. Updated nightly. This page does not constitute medical advice. Drug availability and PBS listing status may change. Verify current availability and PBS coverage with your doctor or pharmacist.